J. Dowell

发表

Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.

Joe Y. Chang, P. Iyengar, K. Westover, 2021, JAMA oncology.

Embolic stroke secondary to an indwelling catheter in a patient with a patent foramen ovale: a case report and review of the literature.

M. Brickner, M. E. Brickner, J. Dowell, 2012, Clinical advances in hematology & oncology : H&O.

Case 1. Melanoma in African Americans.

J. Dowell, Yuenan Shen, W. Harford, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Joe Y. Chang, D. Ettinger, L. Chirieac, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Non – Small Cell Lung Cancer, Version 3.2022

Joe Y. Chang, D. Ettinger, L. Chirieac, 2022 .

Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension.

J. Dowell, Y. Arriaga, J. Liticker, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Looking Beyond Surveillance, Epidemiology, and End Results: Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population

Yang Xie, D. Gerber, D. Rasco, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A randomized Phase II trial in patients with carcinoma of an unknown primary site

David H. Johnson, Y. Shyr, J. Dowell, 2001, Cancer.

Modern management of malignant pleural mesothelioma

J. Dowell, Shivani C. Patel, Shivani Patel, 2016, Lung Cancer.

Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases

J. Reisch, D. Gerber, Elizabeth McGehee, 2019, Clinical lung cancer.

Antiangiogenic therapies for mesothelioma.

H. Kindler, J. Dowell, 2005, Hematology/oncology clinics of North America.

Cancer chemotherapy targeted at reactivating the expression of epigenetically inactivated genes.

J. Minna, J. Dowell, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancer.

S. Huerta, Jeffrey Meyer, David H. Wang, 2015, Surgery.

EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer

J. Minna, J. Dowell, 2006, Nature Clinical Practice Oncology.

The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy

J. Minna, J. Dowell, 2004, Nature Clinical Practice Oncology.

ERCC1 expression and outcomes in head and neck cancer treated with concurrent cisplatin and radiation.

Yang Xie, J. Dowell, Jingsheng Yan, 2011, Anticancer research.

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

S. Cedrés, D. Planchard, K. Yoh, 2020, Investigational New Drugs.

Consent timing and experience: modifiable factors that may influence interest in clinical research.

C. Skinner, Yang Xie, D. Gerber, 2012, Journal of oncology practice.

The impact of consenter characteristics and experience on patient interest in clinical research.

C. Skinner, D. Gerber, D. Rasco, 2009, The oncologist.

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

Edward S. Kim, M. Socinski, V. Velcheti, 2022, Nature Medicine.

Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial.

Xian-Jin Xie, A. Christie, P. Iyengar, 2015, International journal of radiation oncology, biology, physics.

Hematologic malignancies associated with germ cell tumors

Guang Zhao, J. Dowell, 2012, Expert review of hematology.

Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients

E. Pan, J. Dowell, Sumanth P. Reddy, 2020, Clinical & Experimental Metastasis.

Incidence of Isolated Heparin-Induced Thrombocytopenia and Risk of Thrombosis by IgG-Specific Anti-PF4/Heparin ELISA

E. Frenkel, R. Sarode, J. Dowell, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Evaluation of Clinical Pharmacy Services in a Hematology/Oncology Outpatient Setting

J. Dowell, S. Greene, Sachin R. Shah, 2006, The Annals of pharmacotherapy.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

Joe Y. Chang, D. Ettinger, L. Chirieac, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Targeted therapy: what does the internist really need to know?

J. Dowell, 2017 .

Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid

J. Dowell, G. Jean, Sachin R. Shah, 2010, Supportive Care in Cancer.

Rectal GI stromal tumor mimicking a prostate mass.

Wareef Kabbani, A. Ghobadi, J. Dowell, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to letter titled: blood pressure monitoring in patients receiving bevacizumab.

J. Dowell, J. Liticker, S. R. Shah, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Retrospective Analysis of the Consequences of Acid Suppressive Therapy on Ketoconazole Efficacy in Advanced Castration-Resistant Prostate Cancer

J. Dowell, G. Jean, Sachin R. Shah, 2010, The Annals of pharmacotherapy.

A Phase II trial of 6-Hydroxymethylacylfulvene (MGI-114, Irofulven) in Patients with Advanced Non-Small Cell Cancer Previously Treated with Chemotherapy

Y. Shyr, J. Dowell, R. Devore, 2004, Investigational New Drugs.

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

P. Iyengar, K. Westover, H. Choy, 2018, JAMA oncology.

A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma.

Yang Xie, D. Gerber, H. Kindler, 2012, Lung cancer.

Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

P. Iyengar, H. Choy, R. Timmerman, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

D. Gerber, Quanzhen Li, E. Wakeland, 2022, Cancers.

Vemurafenib: targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies.

J. Dowell, Sachin R. Shah, Anant Sharma, 2012, Drugs.

The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.

Weina Chen, J. Dowell, C. Tirado, 2012, Cancer genetics.

TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer

J. Minna, M. Peyton, Masaya Takahashi, 2018, The Journal of clinical investigation.

A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).

T. Owonikoko, S. Ramalingam, D. Gerber, 2015, Lung cancer.

Predictors and Impact of Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer in the United States: Real-World Considerations for Maintenance Therapy

Yang Xie, D. Gerber, D. Rasco, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Small Cell Lung Cancer: Are We Making Progress?

J. Dowell, 2010, The American journal of the medical sciences.

Chasing mutations in the epidermal growth factor in lung cancer.

J. Minna, J. Dowell, 2005, The New England journal of medicine.

Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Basic Science Discovery with Immediate Clinical Impact

J. Dowell, 2006, The American journal of the medical sciences.

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

Yang Xie, D. Gerber, Xin Luo, 2018, British Journal of Cancer.

Putting lung cancer clinical trials into perspective.

J. Schiller, J. Dowell, 2011, Oncology.

Erlotinib hydrochloride.

Peter Kirkpatrick, John D Minna, J. Minna, 2005, Nature reviews. Drug discovery.

Survival in small cell lung cancer is independent of tumor expression of VEGF and COX-2.

J. Minna, W. Frawley, J. Dowell, 2004, Anticancer research.

Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer.

H. Choy, L. C. Cho, J. Dowell, 2005, Seminars in oncology.

Cancer from an Unknown Primary Site

N. Kaplan, B. Palmer, J. Dowell, 2003, The American journal of the medical sciences.

Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors.

Anant Sharma, David H. Wang, Daniel H Ahn, 2013, Journal of oncology practice.

Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway

K. Dunbar, Qiuyang Zhang, T. Pham, 2021, Molecular Cancer Therapeutics.

Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date

J. Dowell, P. A. Levin, 2017, OncoTargets and therapy.

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer.

Yang Xie, D. Gerber, J. Schiller, 2015, Lung cancer.

Phase 1/2 Dose Escalating Study of Twice-Monthly Pemetrexed and Gemcitabine in Patients with Advanced Cancer and Non-small Cell Lung Cancer

T. Larson, C. Obasaju, K. Pandya, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Osimertinib in Pulmonary Manifestations: Two Case Reports and Review of the Literature

J. Dowell, Hannah Lu, 2019, In Vivo.

A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871

G. Rosner, M. Relling, M. Ratain, 2007, Clinical Cancer Research.

NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

Joe Y. Chang, D. Ettinger, L. Chirieac, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Erythroblastic Synartesis in a Patient With Low Grade B Cell Lymphoma

David H. Wang, J. Dowell, Anant Sharma, 2014 .

Small-cell lung cancer: translational research enroute to therapeutic advances.

J. Minna, J. Dowell, 2008, Oncology.

Erlotinib hydrochloride

J. Minna, P. Kirkpatrick, J. Dowell, 2005, Nature reviews. Drug discovery.